INKT vs GILD: Which Stock is Better?
Side-by-side comparison of Mink Therapeutics Inc and Gilead Sciences Inc in 2026
INKT
Mink Therapeutics Inc
$12.94
GILD
Gilead Sciences Inc
$139.77
Key Metrics Comparison
| Metric | INKT | GILD | Winner |
|---|---|---|---|
| Market Cap | $67.09M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze INKT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INKT or GILD a better investment?
Comparing INKT and GILD: Mink Therapeutics Inc has a market cap of $67.09M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INKT and GILD?
INKT (Mink Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INKT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INKT or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for INKT.
Which company is more profitable: INKT or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for INKT.
Which is the larger company: INKT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $67.09M for INKT.
Should I buy INKT or GILD in 2026?
Both INKT and GILD have investment merit. INKT trades at $12.94 while GILD trades at $139.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INKT and GILD stock?
Key differences: Market Cap ($67.09M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).